Office Management of Pediatric Primary Nocturnal Enuresis

A Comparison of Physician Advised and Parent Chosen Alternative Treatment Outcomes

Dawn Diaz Saldano*, Antonio H. Chaviano, Max Maizels, Elizabeth B Yerkes, Earl Y Cheng, Jennifer Losavio, Sima P. Porten, Christine Sullivan, Kerry F. Zebold, Jennifer Hagerty, William E Kaplan

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: We compared the remission of pediatric primary nocturnal enuresis in groups of children who used a physician advised practice plan vs a parent chosen alternative. Materials and Methods: Between January 2004 and January 2006 there were 119 patients with primary nocturnal enuresis enrolled in this prospective, nonrandomized study. For this study primary nocturnal enuresis was defined as wetting at night during sleep during any 6-month interval without any known causative problem. A total of 76 children received the physician advised treatment plan and used an alarm, oxybutynin, desmopressin, an elimination diet and a bowel program, as indicated. A total of 43 children received a parent chosen alternative treatment plan, which consisted of any single or combination of treatments involving an alarm, oxybutynin, desmopressin and an elimination diet or bowel program. Parents from each group completed an intake survey that measured functional bladder capacity using a 3-day home diary and they identified demographic variables. Followup occurred at 2 weeks and then monthly for 12 weeks to study end. Results: We found that the probability of remission by the end of the study for the physician advised treatment group was significantly higher than that of the parent choice group (88% vs 29%, Kaplan-Meier curve p <0.0001). Conclusions: The group of children who followed physician advised treatment for primary nocturnal enuresis showed significantly earlier remission of primary nocturnal enuresis than children who followed the parent choice treatment (25th percentile 2 vs 10 weeks).

Original languageEnglish (US)
Pages (from-to)1758-1762
Number of pages5
JournalJournal of Urology
Volume178
Issue number4 SUPPLEMENT
DOIs
StatePublished - Jan 1 2007

Fingerprint

Office Management
Nocturnal Enuresis
Pediatrics
Physicians
Deamino Arginine Vasopressin
Therapeutics
Diet
Sleep
Urinary Bladder
Parents
Demography
Prospective Studies

Keywords

  • bladder
  • deamino arginine vasopressin
  • nocturnal enuresis
  • parents
  • questionnaires

ASJC Scopus subject areas

  • Urology

Cite this

Diaz Saldano, Dawn ; Chaviano, Antonio H. ; Maizels, Max ; Yerkes, Elizabeth B ; Cheng, Earl Y ; Losavio, Jennifer ; Porten, Sima P. ; Sullivan, Christine ; Zebold, Kerry F. ; Hagerty, Jennifer ; Kaplan, William E. / Office Management of Pediatric Primary Nocturnal Enuresis : A Comparison of Physician Advised and Parent Chosen Alternative Treatment Outcomes. In: Journal of Urology. 2007 ; Vol. 178, No. 4 SUPPLEMENT. pp. 1758-1762.
@article{792bcc703e1c465a9fbabc853bada547,
title = "Office Management of Pediatric Primary Nocturnal Enuresis: A Comparison of Physician Advised and Parent Chosen Alternative Treatment Outcomes",
abstract = "Purpose: We compared the remission of pediatric primary nocturnal enuresis in groups of children who used a physician advised practice plan vs a parent chosen alternative. Materials and Methods: Between January 2004 and January 2006 there were 119 patients with primary nocturnal enuresis enrolled in this prospective, nonrandomized study. For this study primary nocturnal enuresis was defined as wetting at night during sleep during any 6-month interval without any known causative problem. A total of 76 children received the physician advised treatment plan and used an alarm, oxybutynin, desmopressin, an elimination diet and a bowel program, as indicated. A total of 43 children received a parent chosen alternative treatment plan, which consisted of any single or combination of treatments involving an alarm, oxybutynin, desmopressin and an elimination diet or bowel program. Parents from each group completed an intake survey that measured functional bladder capacity using a 3-day home diary and they identified demographic variables. Followup occurred at 2 weeks and then monthly for 12 weeks to study end. Results: We found that the probability of remission by the end of the study for the physician advised treatment group was significantly higher than that of the parent choice group (88{\%} vs 29{\%}, Kaplan-Meier curve p <0.0001). Conclusions: The group of children who followed physician advised treatment for primary nocturnal enuresis showed significantly earlier remission of primary nocturnal enuresis than children who followed the parent choice treatment (25th percentile 2 vs 10 weeks).",
keywords = "bladder, deamino arginine vasopressin, nocturnal enuresis, parents, questionnaires",
author = "{Diaz Saldano}, Dawn and Chaviano, {Antonio H.} and Max Maizels and Yerkes, {Elizabeth B} and Cheng, {Earl Y} and Jennifer Losavio and Porten, {Sima P.} and Christine Sullivan and Zebold, {Kerry F.} and Jennifer Hagerty and Kaplan, {William E}",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/j.juro.2007.03.195",
language = "English (US)",
volume = "178",
pages = "1758--1762",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4 SUPPLEMENT",

}

Diaz Saldano, D, Chaviano, AH, Maizels, M, Yerkes, EB, Cheng, EY, Losavio, J, Porten, SP, Sullivan, C, Zebold, KF, Hagerty, J & Kaplan, WE 2007, 'Office Management of Pediatric Primary Nocturnal Enuresis: A Comparison of Physician Advised and Parent Chosen Alternative Treatment Outcomes', Journal of Urology, vol. 178, no. 4 SUPPLEMENT, pp. 1758-1762. https://doi.org/10.1016/j.juro.2007.03.195

Office Management of Pediatric Primary Nocturnal Enuresis : A Comparison of Physician Advised and Parent Chosen Alternative Treatment Outcomes. / Diaz Saldano, Dawn; Chaviano, Antonio H.; Maizels, Max; Yerkes, Elizabeth B; Cheng, Earl Y; Losavio, Jennifer; Porten, Sima P.; Sullivan, Christine; Zebold, Kerry F.; Hagerty, Jennifer; Kaplan, William E.

In: Journal of Urology, Vol. 178, No. 4 SUPPLEMENT, 01.01.2007, p. 1758-1762.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Office Management of Pediatric Primary Nocturnal Enuresis

T2 - A Comparison of Physician Advised and Parent Chosen Alternative Treatment Outcomes

AU - Diaz Saldano, Dawn

AU - Chaviano, Antonio H.

AU - Maizels, Max

AU - Yerkes, Elizabeth B

AU - Cheng, Earl Y

AU - Losavio, Jennifer

AU - Porten, Sima P.

AU - Sullivan, Christine

AU - Zebold, Kerry F.

AU - Hagerty, Jennifer

AU - Kaplan, William E

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Purpose: We compared the remission of pediatric primary nocturnal enuresis in groups of children who used a physician advised practice plan vs a parent chosen alternative. Materials and Methods: Between January 2004 and January 2006 there were 119 patients with primary nocturnal enuresis enrolled in this prospective, nonrandomized study. For this study primary nocturnal enuresis was defined as wetting at night during sleep during any 6-month interval without any known causative problem. A total of 76 children received the physician advised treatment plan and used an alarm, oxybutynin, desmopressin, an elimination diet and a bowel program, as indicated. A total of 43 children received a parent chosen alternative treatment plan, which consisted of any single or combination of treatments involving an alarm, oxybutynin, desmopressin and an elimination diet or bowel program. Parents from each group completed an intake survey that measured functional bladder capacity using a 3-day home diary and they identified demographic variables. Followup occurred at 2 weeks and then monthly for 12 weeks to study end. Results: We found that the probability of remission by the end of the study for the physician advised treatment group was significantly higher than that of the parent choice group (88% vs 29%, Kaplan-Meier curve p <0.0001). Conclusions: The group of children who followed physician advised treatment for primary nocturnal enuresis showed significantly earlier remission of primary nocturnal enuresis than children who followed the parent choice treatment (25th percentile 2 vs 10 weeks).

AB - Purpose: We compared the remission of pediatric primary nocturnal enuresis in groups of children who used a physician advised practice plan vs a parent chosen alternative. Materials and Methods: Between January 2004 and January 2006 there were 119 patients with primary nocturnal enuresis enrolled in this prospective, nonrandomized study. For this study primary nocturnal enuresis was defined as wetting at night during sleep during any 6-month interval without any known causative problem. A total of 76 children received the physician advised treatment plan and used an alarm, oxybutynin, desmopressin, an elimination diet and a bowel program, as indicated. A total of 43 children received a parent chosen alternative treatment plan, which consisted of any single or combination of treatments involving an alarm, oxybutynin, desmopressin and an elimination diet or bowel program. Parents from each group completed an intake survey that measured functional bladder capacity using a 3-day home diary and they identified demographic variables. Followup occurred at 2 weeks and then monthly for 12 weeks to study end. Results: We found that the probability of remission by the end of the study for the physician advised treatment group was significantly higher than that of the parent choice group (88% vs 29%, Kaplan-Meier curve p <0.0001). Conclusions: The group of children who followed physician advised treatment for primary nocturnal enuresis showed significantly earlier remission of primary nocturnal enuresis than children who followed the parent choice treatment (25th percentile 2 vs 10 weeks).

KW - bladder

KW - deamino arginine vasopressin

KW - nocturnal enuresis

KW - parents

KW - questionnaires

UR - http://www.scopus.com/inward/record.url?scp=34548448914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548448914&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2007.03.195

DO - 10.1016/j.juro.2007.03.195

M3 - Article

VL - 178

SP - 1758

EP - 1762

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4 SUPPLEMENT

ER -